Table 3. Baseline characteristics of the T2D (n = 54) and non-T2D (n = 43) study population.
| Non-T2D (n = 43) | T2D (n = 54) | |||||
|---|---|---|---|---|---|---|
| Parameter | Lean (n = 11) | Overweight (n = 14) | Obese (n = 18) | Lean (n = 10) | Overweight (n = 11) | Obese (n = 33) |
| Age (yr) | 61.63 ± 2.42 | 58.64 ± 1.80 | 61.38 ± 1.54 | 68.00 ± 2.77 | 65.36 ± 1.82 | 54.81 ± 2.45 |
| BW (kg) | 59.18 ± 1.90 | 69.48 ± 1.86 | 86.88 ± 2.26 | 52.90 ± 1.72 | 68.03 ± 1.93 | 92.41 ± 2.40 |
| BMI (kg/m2) | 22.87 ± 0.64 | 27.07 ± 0.33 | 35.53 ± 0.79 | 21.55 ± 0.59 | 27.23 ± 0.38 | 36.30 ± 0.82 |
| HbA1c (%) | 5.68 ± 0.07 | 5.65 ± 0.08 | 5.90 ± 0.08 | 7.35 ± 0.26 | 8.31 ± 0.64 | 7.90 ± 0.35 |
| FBG (mg/dl) | 87.54 ± 2.12 | 88.85 ± 1.84 | 91.72 ± 2.46 | 118.90 ± 13.2 | 167.0 ± 23.79 | 160.81 ± 15.6 |
| LCN2 (ng/ml) | 58.58 ± 7.61 | 85.84 ± 7.09 | 79.88 ± 3.83 | 82.88 ± 8.84 | 89.21 ± 12.09 | 87.97 ± 7.04 |
Data are presented as means ± SEM. FBG, fasting blood glucose; HbA1c, glycated hemoglobin.